• 1. Evolution of hierarchical porous structures in supramolecular guest–host hydrogels?
  Christopher B. Rodell,Christopher B. Highley,Minna H. Chen,Neville N. Dusaj,Chao Wang,Lin Han,Jason A. Burdick Soft Matter, 2016,12, 7839-7847
• 2. Evolution of dealloying induced strain in nanoporous gold crystals?
  Ross Harder,David C. Dunand,Ian McNulty Nanoscale, 2017,9, 5686-5693
• 3. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 4. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 5. Fast synthesis of copper nanoclusters through the use of hydrogen peroxide additive and their application for the fluorescence detection of Hg2+ in water samples?
  Liao Xiaoqing,Li Ruiyi,Li Zaijun,Sun Xiulan,Wang Zhouping,Liu Junkang New J. Chem., 2015,39, 5240-5248

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Tertiary amines

2-((6-Chloropyrimidin-4-yl)(ethyl)amino)ethan-1-ol: A Comprehensive Overview

The compound 2-((6-chloropyrimidin-4-yl)(ethyl)amino)ethan-1-ol (CAS No. 1220020-02-9) is a structurally complex organic molecule with significant potential in various chemical and pharmaceutical applications. This compound belongs to the class of pyrimidine derivatives, which are well-known for their diverse biological activities and roles in drug design. The molecule's structure features a 6-chloropyrimidine ring substituted at the 4-position with an N-(ethylamino)ethanol group, making it a unique member of the pyrimidine family.

Recent advancements in synthetic chemistry have enabled the efficient synthesis of 6-chloropyrimidine derivatives, including our compound of interest. Researchers have employed various methodologies, such as the Biginelli reaction and Hantzsch dihydropyridine synthesis, to construct pyrimidine frameworks with high precision. These methods not only enhance the yield but also allow for fine-tuning of substituents, which is crucial for optimizing biological activity.

The 6-chloropyrimidinyl group in this compound plays a pivotal role in determining its physicochemical properties and biological behavior. Chlorine substitution at the 6-position introduces electron-withdrawing effects, which can modulate the molecule's reactivity and stability. This substitution pattern is particularly advantageous in drug design, where such modifications can enhance pharmacokinetic profiles, including absorption, distribution, metabolism, and excretion (ADME).

One of the most promising applications of 2-((6-chloropyrimidin-4-yl)(ethyl)amino)ethan-1-ol lies in its potential as a lead compound for developing novel therapeutic agents. Recent studies have highlighted its ability to inhibit key enzymes involved in inflammatory pathways, making it a candidate for anti-inflammatory drug development. Additionally, its structural versatility allows for further functionalization, enabling researchers to explore its potential in other therapeutic areas such as oncology and neurodegenerative diseases.

In terms of synthesis, the compound can be prepared via a multi-step process involving nucleophilic substitution and condensation reactions. The introduction of the ethylaminoethanol group is typically achieved through reductive amination or similar techniques, ensuring high stereochemical control. This approach not only simplifies scalability but also ensures compliance with Good Manufacturing Practices (GMP), which is essential for pharmaceutical applications.

The pyrimidine ring system in this compound is highly versatile, allowing for additional substitutions that can further tailor its properties. For instance, introducing electron-donating groups at specific positions can enhance its solubility and bioavailability, while electron-withdrawing groups can improve its binding affinity to target proteins. Such modifications are critical in addressing challenges related to drug delivery and efficacy.

From an environmental perspective, the synthesis and application of 2-((6-chloropyrimidin-4-yl)(ethyl)amino)ethan-1-ol align with sustainable chemistry principles. Researchers have developed eco-friendly protocols that minimize waste generation and reduce reliance on hazardous reagents. These advancements not only contribute to environmental protection but also lower production costs, making the compound more accessible for large-scale applications.

In conclusion, 2-((6-chloropyrimidin-4-y1)(ethyl)amino)ethan1 ol (CAS No. 1220020 02 9) represents a valuable addition to the portfolio of pyrimidine derivatives with immense potential across multiple disciplines. Its unique structure, combined with recent advances in synthetic methods and biological applications, positions it as a key player in future drug discovery efforts.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)